Cellular immune responses to human islet proteins in antibody-positive type 2 diabetic patients
Cellular immune responses to human islet proteins in antibody-positive type 2 diabetic patients
复制标题
DOI:
10.2337/diabetes.48.5.983
复制
发表时间:
1999-05-01
期刊:
影响因子:
7.7
通讯作者:
Palmer, JP
中科院分区:
文献类型:
--
作者:
Brooks-Worrell, BM;Juneja, R;Palmer, JP
Type 1 diabetes is a cell-mediated autoimmune disease characterized by autoantibody and peripheral blood mononuclear cell (PBMC) reactivity to islet cell proteins. Type 2 diabetes is not an autoimmune disease but rather results from both insulin resistance and a nonautoimmune insulin secretory defect. There is, however, a group of phenotypic type 2 diabetic patients who have islet autoantibodies that are similar to those of type 1 diabetic patients. In this study, we investigated, using cellular immunoblotting, whether type 2 diabetic patients positive for islet autoantibodies have PBMC responses to islet proteins. We observed that autoantibody negative (Ab(-)) type 2 diabetic patients (n = 9) and normal control subjects (n = 12) demonstrated PBMCs responsive to 0-3 molecular weight regions, In contrast, autoantibody positive (Ab(+)) type 2 diabetic patients (n = 11) demonstrated PBMC responses to 3-18 molecular weight regions, similar to that of type 1 diabetic patients (responsive to 4-18 molecular weight regions). PBMCs from over 90% of the Ab(+) type 2 and type 1 diabetic patients were observed to proliferate to islet proteins in the vicinity of 97 kDa, In contrast, 65-90% of type 1 diabetic patients had responsive PBMCs for islet proteins in most of the molecular weight regions, whereas